Skip to Content

Addressing Immunosenescence: A Vital Concern for Elderly MS Patients

Vincent Van Pesch, a neurologist from Clinique Universitaire Saint-Luc in Belgium, discusses the importance of addressing immunosenescence in multiple sclerosis (MS) among elderly patients. As people with MS are living longer, the aging of the immune system can lead to increased susceptibility to infections, reduced vaccine response, and possibly higher autoreactive cell reactivity. This, coupled with disease-modifying treatments, may increase the risk of infections and cancer, particularly with high-efficacy therapies.

Vincent Van Pesch

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top